IMVT Competitors & Alternatives
Compare Immunovant Inc with similar stocks in the same industry
Biotechnology
IMVT
Main Stock$28.38
Tradestie Score
54
Market Cap
$2.85B
Analyst Upside
+72.2%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CYTK
Cytokinetics Inc.
|
$62.86
|
$6.68B | - | 66 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$88.62
|
$6.64B | - | 71 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$93.49
|
$6.38B | - | 59 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$18.63
|
$6.03B | - | 49 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$50.50
|
$6.02B | - | 64 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$156.31
|
$5.92B | - | 51 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$53.20
|
$5.80B | 19.8 | 58 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$322.17
|
$5.20B | 40.8 | 61 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$63.23
|
$4.94B | - | 46 | Compare |
More IMVT Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
219 stocks in this industry